An official website of the United States government
Government Funding Lapse Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants with Melanoma and Their Families
Trial Status: active
This trial studies how well Young Melanoma Family Facebook intervention or Healthy Lifestyle Facebook intervention works in improving skin examination in participants with melanoma and their families. Young Melanoma Family Facebook intervention or Healthy Lifestyle Facebook intervention may help improve total cutaneous examinations, skin self-examinations, and sun protection among first degree relatives of young onset participants and the participants themselves.
Inclusion Criteria
PATIENT: Diagnosed with stage 0-3 melanoma in the last 5 years
PATIENT: Age at diagnosis 18-39 years
PATIENT: Completed treatment at least 3 months previously
PATIENT: Recruited from New Jersey or California State Cancer Registry or MD Anderson Cancer Center
PATIENT: Does not have a concurrent cancer diagnosis
PATIENT: Able to speak and read English
PATIENT: Access to computer, internet, and has a Facebook account
PATIENT: At least one family member consents
FDR: Current age 18-80 years
FDR: Does not have a personal history of melanoma
FDR: Able to speak and read English
FDR: Access to computer, internet, and has a Facebook account
FDR: Has only one FDR with melanoma (patient)
FDR: Has not had a total cutaneous examination (TCE) in the past 3 years, has done skin self-exam (SSE) fewer than three times in the past year, OR has a sun protection habits average score less than or equal to 4 (“often”)
FDR: Patient consents
Exclusion Criteria
Physical Activity Readiness Questionnaire (Thomas, et. al., 1992): This 7-item scale will be used to screen out individuals who will need to consult a physician for medical clearance before engaging in physical activity based on a human subjects concern raised during National Institutes of Health (NIH) review due to the fact that the comparison condition covers behaviors including physical activity. If a participant checks off any of the items, we will ask for a physician clearance before consenting to study as a precaution, so the study is not posting information on physical activity to those individuals who are not health enough for exercise
Additional locations may be listed on ClinicalTrials.gov for NCT03677739.
I. To examine the efficacy of the Young Melanoma Family Facebook intervention versus the Healthy Lifestyle Facebook intervention on total cutaneous exam (primary outcome), skin self-exam frequency and comprehensiveness, and sun protection practices (secondary outcomes) of first degree relatives (FDRs) of young melanoma survivors.
SECONDARY OBJECTIVES:
I. To examine the efficacy of the Young Melanoma Family Facebook intervention on patients’ skin self-exam frequency and comprehensiveness and sun protection habits.
II. To examine the mechanisms of intervention efficacy.
OUTLINE:
PHASE I: Researchers refine content for the Facebook intervention condition and conduct usability testing.
PHASE II: Participants are randomized to 1 of 2 arms.
ARM I: Participants join a secret Young Melanoma Family Facebook Group and view post messages focusing on skin cancer for 12 weeks.
ARM II: Participants join a secret Healthy Lifestyle Facebook Group and view post messages focusing on healthy lifestyle for 12 weeks.
PHASE III: Dissemination planning.
After completion of study, participants are followed up at 6 months.
Trial PhaseNo phase specified
Trial Typeprevention
Lead OrganizationRutgers Cancer Institute of New Jersey